NYU Langone Laura and Isaac Perlmutter Cancer Center — New York, New York

NYU Langone Laura and Isaac Perlmutter Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Laura and Isaac Perlmutter Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Gynecologic Cancer, Non-Squamous Non-small Cell Lung Cancer.

Sponsors: Clovis Oncology, Inc., Summit Therapeutics.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Laura and Isaac Perlmutter Cancer Center?

NYU Langone Laura and Isaac Perlmutter Cancer Center has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Laura and Isaac Perlmutter Cancer Center conducted?

NYU Langone Laura and Isaac Perlmutter Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Gynecologic Cancer, Non-Squamous Non-small Cell Lung Cancer.

Is NYU Langone Laura and Isaac Perlmutter Cancer Center accredited by Crixeo Health?

NYU Langone Laura and Isaac Perlmutter Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Laura and Isaac Perlmutter Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.